SEC Form 4 · accession 0001437749-16-028260
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Gregory S Skinner
Officer — VP Finance and Admin & CFO
Period of report
Mar 21, 2016
Accepted (ET)
Mar 23, 2016 · 11:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 21, 2016 | M | 22,500 | $6.22 | A | 256,443 | D | |
| Common StockF1 | Mar 21, 2016 | M | 12,815 | $10.92 | D | 243,628 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $10.92 | Mar 21, 2016 | X | 22,500 | D | May 21, 2012 | May 21, 2016 | Common Stock | 22,500 | 0 | D |
Explanation of responses
- F1Mr Skinner surrendered to the Issuer the right to receive an aggregate of 12,815 shares of Common Stock. Mr. Skinner did not sell any shares of Common Stock in connection with the foregoing exercise.